The new study shows that the synthetic compound is capable of inhibiting the activities of several DNA - processing enzymes, including the «integrase»
used by the Human Immunodeficiency Virus (HIV) to insert its genome into that of its host cell.
By supporting Directive 2010 / 63 / EU, LERU wishes to call attention to the fundamental importance of the
use of animals in research and the vital role it plays in understanding and providing treatment for a range of debilitating and life threatening
human diseases such as cancer, primary
immunodeficiencies, neuro - degenerative diseases and heart failure.